Atlas Trials

Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders.

Clinical trial NCT07564245 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07564245
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neurodevelopmental Disorders With Severe Self-injuries
Start date
2026-05-01
Primary completion
2029-05-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.